Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-02-20 @ 12:46 PM
Study NCT ID:
NCT05421858
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2022-06-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Sponsor:
Basilea Pharmaceutica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-07
First Submit QC Date:
None
Study First Post Date:
2022-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED